FOXM1 and Miyoshi myopathy: To determine if FOXM1 is a relevant therapeutic target in MM, we examined FOXM1 expression in tissue arrays of human MM tumor specimens with a polyclonal FOXM1 antibody at multiple dilutions (1∶1000, 1∶2000 and 1∶3000), as in another study [31].